Universal Health Services Inc. Cl B Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones11-02

DJ Universal Health Services Inc. Cl B Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Universal Health Services Inc. Cl B $(UHS)$ inched 0.46% higher to $205.26 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.41% to 5,728.80 and the Dow Jones Industrial Average rising 0.69% to 42,052.19.

Universal Health Services Inc. Cl B closed $37.99 below its 52-week high ($243.25), which the company reached on September 24th.

The stock underperformed when compared to some of its competitors Friday, as Select Medical Holdings Corp. (SEM) rose 12.06% to $35.95, Community Health Systems Inc. (CYH) rose 3.70% to $4.20, and Pediatrix Medical Group Inc. (MD) rose 23.46% to $15.21.

Trading volume (626,995) remained 118,462 below its 50-day average volume of 745,457.

Data source: Dow Jones Market Data, FactSet. Data compiled November 1, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 01, 2024 17:17 ET (21:17 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment